Company / Total Assets
Corcept Therapeutics Incorporated Total Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$836.7M
FY2025
5-year range
$423.8M / $840.6M
FY2021-FY2025
Trend
-0.5%
vs FY2024
Sector context
#92 of 214
Health Care
What the data says
At $837M, Corcept Therapeutics Incorporated's total assets ranks #92 of 214 in the Health Care sector. Total Assets has fluctuated over the past 10 years, ranging from $69M in FY2016 to $841M in FY2024.
Based on SEC 10-K filings.
$837M in FY2025 with a 5-year CAGR of +7.9%.
Improved from $622M to $837M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +12.8%
- 5-Year CAGR
- +7.9%
- 10-Year CAGR
- -
Sector benchmark
#92 of 214 in Health CareTop 43% of 214This company $836.7M Sector average $7.5B
▼
-88.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +7.9%, indicating consistent growth.
- In FY2025, total assets decreased 0.5% year-over-year.
- Ranks #92 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 3.44 (safe zone, above 2.9 threshold)
- Strong profit margin: 20.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $836.7M | -0.5% |
| FY2024 | $840.6M | +35.2% |
| FY2023 | $621.5M | +6.5% |
| FY2022 | $583.4M | +37.7% |
| FY2021 | $423.8M | -25.9% |
| FY2020 | $571.7M | +38.7% |
| FY2019 | $412.3M | +32.3% |
| FY2018 | $311.7M | +41.3% |
| FY2017 | $220.5M | +220.8% |
| FY2016 | $68.8M | +32.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026